Recovery Cat is a spin-off of the Charité - Universitätsmedizin Berlin and the Berlin Institute of Health at Charité (BIH) originating from the Department of Psychiatry and Neuroscience at Campus Mitte. The start-up has developed a digital platform to help people with severe mental disorders such as schizophrenia, bipolar disorder and recurrent depression, who currently in Germany are not adequately served by digital healthcare management. Practitioners and patients create therapy and medication plans together, and can follow progress with the help of the software in order to recognize potential crises as early as possible, thus reducing the need for in-patient care.
The software is already being evaluated in a clinical study, and a soft-launch is planned for Q1 2023. Recovery Cat will use the seed financing to finalize approval of the software as a medical device, enter initial reimbursement agreements with health insurers, and close B2B contracts with hospitals. Further clinical studies are also planned for 2023, as well as the development of statistical methods for improved therapy follow-up.
The foundations for Recovery Cat were laid by the BIH Digital Health Accelerator programme from Charité BIH Innovation, who supported the project from 2020 until Recovery Cat was founded in Autumn 2022. The licensing agreement between the Charité and Recovery Cat, as well as the start-up agreements, were negotiated by Ascenion together with the patenting and licensing team at Charité BIH Innovation. Ascenion subsequently acquired shares in Recovery Cat.
Further information:
BIH's press release
IBB's press release (in German only)